Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

VK bought the Yclients platform

12/21/23 VKCO

Shareholders of Sovcomflot approved dividends

12/20/23 FLOT

Lukoil to expand presence in Egypt

12/20/23 LKOH

MTS transferred 7.4% of its shares to the CEIF

12/20/23 MTSS

Yandex began to rent delivery robots to residential complexes

12/20/23 YNDX

Rostelecom invests in a platform for business tourism automation

12/20/23 RTKM

Moscow Exchange launched a beta version of a service for algorithmic trading

12/20/23 MOEX

Softline shares its plans for 2024

12/20/23 SOFL

Kristall Plant postpones IPO to January 2024

12/20/23 KLVZ

United Medical Group receipts go for conversion

12/20/23 GEMC